SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-18-325600
Filing Date
2018-11-13
Accepted
2018-11-13 17:03:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d652788dsc13da.htm SC 13D/A 46656
2 EX-99.13 d652788dex9913.htm EX-99.13 22116
3 GRAPHIC g652788g1110015619564.jpg GRAPHIC 3063
  Complete submission text file 0001193125-18-325600.txt   74743
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filed by) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Subject) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88828 | Film No.: 181178922
SIC: 2834 Pharmaceutical Preparations